Saba Capital Management’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Saba Capital Management’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-817,821	Closed	-$8.24M	–	956
2022 Q4	$8.24M	Hold	817,821	–	–	0.11%	301
2022 Q3	$8.1M	Hold	817,821	–	–	0.09%	402
2022 Q2	$8M	Hold	817,821	–	–	0.09%	397
2022 Q1	$8M	Hold	817,821	–	–	0.11%	308
2021 Q4	$7.95M	Buy	817,821 +224,300	+38%	+$2.18M	0.12%	245
2021 Q3	$5.79M	Buy	593,521 +359,159	+153%	+$3.46M	0.14%	200
2021 Q2	$2.26M	Buy	+234,362	New	+$2.29M	0.06%	272

Saba Capital Management's MSAC Position: Q1 2023 in Review

Saba Capital Management sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 817,821 shares — an estimated $8.24M sold.

Saba Capital Management first reported a position in MSAC in Q2 2021 and held it in 7 quarters. The position peaked at $8.24M in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Saba Capital Management reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Saba Capital Management sold 817,821 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $8.24M.
Saba Capital Management first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 7 quarters.
Saba Capital Management's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $8.24M in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Saba Capital Management's 13F filing for Q1 2023, filed 15 May 2023.